Org.nr 982 904 420 2021 → 2022 Year-over-year analysis

NEXT BIOMETRICS GROUP ASA: årsregnskap 2022 vs 2021

Grew 14% on revenue, stronger earnings, cash halved-plus

approved 2023-04-19; registry 2023-07-29; journal 2023 618374

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2022 with 2021 for NEXT BIOMETRICS GROUP ASA. Revenue 8.32m NOK → 9.50m NOK (+14.2%). Net result -19.33m NOK → -10.05m NOK. Equity 265.27m NOK → 259.82m NOK.

On the constructive side: revenue rose; operating result improved; net result improved. Pressures included: equity eroded; cash fell.

Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for NEXT BIOMETRICS GROUP ASA.

Scorecard

Revenue
8.32m NOK 9.50m NOK
+14.2%
Operating result
-21.05m NOK -12.07m NOK
+42.6%
Net result
-19.33m NOK -10.05m NOK
+48.0%
Equity
265.27m NOK 259.82m NOK
-2.1%
Cash
78.20m NOK 38.18m NOK
-51.2%
Total assets
275.04m NOK 268.05m NOK
-2.5%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 8.32m NOK to 9.50m NOK (+14.2% YoY). Calculated

  • ↑

    Operating result improved

    Operating result -21.05m NOK → -12.07m NOK (op. margin -253.0% → -127.0%). Calculated

  • ↑

    Net result improved

    Net result -19.33m NOK → -10.05m NOK (net margin -232.4% → -105.7%). Calculated

  • ↑

    Payroll decreased

    Salary cost 21.70m NOK → 13.75m NOK (261% → 145% of revenue). Calculated

What deteriorated

  • ↓

    Equity eroded

    Book equity 265.27m NOK → 259.82m NOK (equity ratio 96.4% → 96.9%). Calculated

  • ↓

    Cash fell

    Bank deposits 78.20m NOK → 38.18m NOK (-51.2% YoY). Calculated

Things to notice

  • ·

    Paid-in equity reduced

    Paid-in equity fell 265.27m NOK → 209.71m NOK — check capital reduction, conversion, or reclassification. Interpretation

  • ·

    Book investments changed

    Investment / intangible book value 191.89m NOK → 224.40m NOK. Reported fact